Deerfield Management Company, L.P. (Series C) Aerie Pharmaceuticals Inc Transaction History

Deerfield Management Company, L.P. (Series C)

  • $5.38 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$6.37 - $15.23 $1.02 Million - $2.44 Million
159,985 Added 3.41%
4,855,005 $73.5 Million
Q4 2021

Feb 14, 2022
BUY
$7.02 - $13.33 $12.1 Million - $22.9 Million
1,718,000 Added 57.71%
4,695,020 $33 Million
Q3 2021

Nov 15, 2021
BUY
$11.32 - $16.63 $24.4 Million - $35.8 Million
2,151,083 Added 260.44%
2,977,020 $33.9 Million
Q2 2021

Aug 16, 2021
BUY
$15.16 - $18.97 $5.03 Million - $6.29 Million
331,721 Added 67.12%
825,937 $13.2 Million
Q1 2021

May 17, 2021
SELL
$13.12 - $20.9 $8.76 Million - $14 Million
-667,817 Reduced 57.47%
494,216 $8.83 Million
Q4 2020

Feb 16, 2021
BUY
$9.12 - $14.49 $6.09 Million - $9.68 Million
667,817 Added 135.13%
1,162,033 $15.7 Million
Q2 2020

Aug 14, 2020
SELL
$12.0 - $16.13 $24.5 Million - $32.9 Million
-2,037,931 Reduced 80.48%
494,216 $7.3 Million
Q1 2020

May 15, 2020
BUY
$11.84 - $25.52 $9 Million - $19.4 Million
759,892 Added 42.88%
2,532,147 $34.2 Million
Q4 2019

Feb 14, 2020
SELL
$17.72 - $25.1 $49.6 Million - $70.2 Million
-2,796,569 Reduced 61.21%
1,772,255 $42.8 Million
Q3 2019

Nov 14, 2019
BUY
$18.41 - $28.0 $28.3 Million - $43 Million
1,535,837 Added 50.64%
4,568,824 $87.8 Million
Q2 2019

Aug 14, 2019
BUY
$28.97 - $48.21 $41.3 Million - $68.7 Million
1,424,202 Added 88.53%
3,032,987 $89.6 Million
Q1 2019

May 15, 2019
BUY
$36.32 - $49.25 $3.28 Million - $4.44 Million
90,189 Added 5.94%
1,608,785 $76.4 Million
Q4 2018

Feb 14, 2019
SELL
$33.0 - $60.04 $721,116 - $1.31 Million
-21,852 Reduced 1.42%
1,518,596 $54.8 Million
Q3 2018

Nov 14, 2018
BUY
$56.15 - $73.9 $59.3 Million - $78.1 Million
1,056,393 Added 218.24%
1,540,448 $94.8 Million
Q4 2017

Feb 14, 2018
SELL
$50.85 - $65.1 $7.56 Million - $9.68 Million
-148,631 Reduced 23.49%
484,055 $28.9 Million
Q3 2017

Nov 13, 2017
BUY
$48.6 - $60.1 $30.7 Million - $38 Million
632,686
632,686 $30.7 Million

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email